CRNX - Crinetics Pharmaceuticals, Inc.
39.51
-0.610 -1.544%
Share volume: 1,088,475
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$40.12
-0.61
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 640.000 K | 399.000 K | 0.000 | 0.000 | 361.000 K | 1.031 M | 143.000 K | 6.161 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.076 M | |
| Gross profit | 640.000 K | 399.000 K | 0.000 | 0.000 | 361.000 K | 1.031 M | 143.000 K | 5.085 M | |
| -37.66% | -100.00% | nan% | 185.60% | -86.13% | 3,455.94% | ||||
| Operating expenses | 74.169 M | 83.182 M | 87.797 M | 94.745 M | 111.766 M | 130.143 M | 142.729 M | 138.751 M | |
| Selling general and admin | 20.828 M | 24.838 M | 25.892 M | 28.179 M | 35.526 M | 49.842 M | 52.265 M | 53.698 M | |
| Research and development | 53.341 M | 58.344 M | 61.905 M | 66.566 M | 76.240 M | 80.301 M | 90.464 M | 85.053 M | |
| Total expenses | 74.169 M | 83.182 M | 87.797 M | 94.745 M | 111.766 M | 130.143 M | 142.729 M | 138.751 M | |
| 12.15% | 5.55% | 7.91% | 17.97% | 16.44% | 9.67% | -2.79% | |||
| Operating income | -73.529 M | -82.783 M | -87.797 M | -94.745 M | -111.405 M | -129.112 M | -142.586 M | -133.666 M | |
| Ebit | -73.529 M | -82.796 M | -87.834 M | -94.745 M | -111.608 M | -129.092 M | -142.635 M | -133.791 M | |
| Pretax income | -66.679 M | -74.055 M | -76.828 M | -80.846 M | -96.774 M | -115.637 M | -130.091 M | -122.635 M | |
| 11.06% | 3.74% | 5.23% | 19.70% | 19.49% | 12.50% | -5.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -66.930 M | -74.055 M | -76.828 M | -80.595 M | -96.774 M | -115.637 M | -130.091 M | -122.815 M | |
| -10.65% | -3.74% | -4.90% | -20.07% | -19.49% | -12.50% | 5.59% |